10/12/2018New from our Partners: Positive Late-Breaking Phase II Data Evaluating Investigational Oral Therapy,
10/11/2018CMSC InforMS: TG Therapeutics, Inc. Announces Final Phase 2 MS Data Presentation at ECTRIMS
10/10/2018News from our Partners: Novartis announces FDA filing acceptance of siponimod (BAF312)
10/10/2018News from our Partners: Press Release - New Efficacy and Safety Data on MS Portfolio to be Presented
10/10/2018News from our Partners: Press Release - Ocrevus data show early initiation reduces progression
5/28/2019 » 6/1/2019
2019 CMSC Annual Meeting (Seattle, WA)
5/20/2020 » 5/23/2020
2020 CMSC Annual Meeting (Orlando, FL)
6/2/2021 » 6/5/2021
2021 CMSC Annual Meeting (San Diego, CA)
Print Page